Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shuchin J. Shukla"'
Autor:
Marie P. Bresnahan, Ponni V. Perumalswami, Czarina N Behrends, Ashley A. Eggman, Kyle Fluegge, Alain H. Litwin, Jeffrey J. Weiss, Bruce R. Schackman, Fabienne Laraque, Sarah Gutkind, Shuchin J. Shukla, Paul Meissner, Brooke Wyatt
Publikováno v:
J Public Health Manag Pract
OBJECTIVE To estimate the cost of delivering a hepatitis C virus care coordination program at 2 New York City health care provider organizations and describe a potential payment model for these currently nonreimbursed services. DESIGN An economic eva
Autor:
Ponni V. Perumalswami, Jeffrey J. Weiss, Marie P. Bresnahan, Ann Winters, Fabienne Laraque, Kyle Fluegge, Alain H. Litwin, Shuchin J. Shukla
Publikováno v:
Journal of healthcare risk management : the journal of the American Society for Healthcare Risk ManagementREFERENCES. 39(2)
The New York City Department of Health and Mental Hygiene (DOHMH) implemented Project INSPIRE, an integrated model of hepatitis C care coordination and telementoring services, from 2014 to 2017. We evaluated the use of chronic care management (CCM) c
Autor:
Alain H. Litwin, Shuchin J. Shukla, Miranda S. Moore, Ponni V. Perumalswami, Regan Deming, M. M. Ford, S. Lim, Jeffrey J. Weiss, Fabienne Laraque, S. Reynoso, Brooke Wyatt
Publikováno v:
Journal of viral hepatitis. 25(11)
Hepatitis C (HCV) is a viral infection that if left untreated can severely damage the liver. Project INSPIRE was a 3 year HCV care coordination programme in New York City (NYC) that aimed to address barriers to treatment initiation and cure by provid
Autor:
Uriel R. Felsen, Lorlette Moir, Aileen Tlamsa, Alain H. Litwin, Jeffrey M. Weiss, Shuchin J. Shukla, Devin Thompson, Moonseong Heo
Publikováno v:
Open Forum Infectious Diseases
Background HIV and HCV are both treatable viruses for which routine screening among specific age cohorts is recommended. New York State requires patient consent prior to screening for HIV but not HCV. To estimate the impact of the consent requirement
Autor:
Jonathan M. Schwartz, Marie P. Bresnahan, Sheila Reynoso, Shuchin J. Shukla, Alain H. Litwin, Ponni V. Perumalswami, Fabienne Laraque, Jeffrey M. Weiss, Bruce R. Schackman, Paul A. Teixeira, Brooke Wyatt
Publikováno v:
Learning Health Systems
Introduction The recent availability of highly effective, easily administered, and relatively nontoxic treatments for hepatitis C virus (HCV) infection provides an opportunity for clinicians to treat HCV in nonspecialist settings with appropriate sup